Halothane: Ave Atque Vale

Suckling C.W. Some chemcial and physical features in the development of Fluothane. Br J Anaesth 1957; 29: 446–470.

Raventos J. Abstracts of Communications XX International Congress, Brussels, 1956; p. 754.

Raventos J. The Action of Fluothane, a new volatile anaesthetic. Br J Pharmacol 1956; 11: 394.

Johnstone M. The cardiovascular effects of Fluothane. Br J Anaesth 1956; 28: 392.

Epstein H.G. , Macintosh R.R. An anaesthetic inhaler with automatic thermocompensation. Anaesthesia 1956; 11: 83.

Bryce-Smith R. , O'Brien H.D. Fluothane; A non-explosive volatile anaesthetic agent. Br Med J 1956; 2: 969.

Bryce-Smith R. , O'Brien H.D. Some observations on Fluothane. Proc Roy Soc Med 1956; 50: 15.

Summary of the National Halothane Study: Possible association between halothane anaesthesia and post-operative hepatic necrosis. J Amer Med Ass 1966; 197: 775–788.

Simpson B.R. , Strunin L. , Walton B. The halothane dilemma: A case for the defence. Br Med J 1971; 4: 96–100.

Blogg C.E. Halothane and the liver: The problem revisited and made obsolete. Br Med J 1986; 292: 6537, 169.

Editorial. Halothane-associated liver damage. Lancet 1986; 1251.

Cutfield G. Halothane and the liver; Reappraising our approach to patients with postoperative liver dysfunction. Curr Ther 1987; July; 19.

Jones R.M. Desflurane and sevoflurane inhalation anaesthetics for this decade? Br J Anaes 1990; 65: 527–536.